CJC-1295 Cas No.: 863288-34-0　

Alias: CJC-1295 Acetate; CJC1295(Without DAC);

Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Maleimidopropionyl)-NH2

Cas No.: 863288-34-0　

Molecular Formula: C165H271N47O46

Molecular Weight: 3649.30

Purity (HPLC): 98.0%

Appearance: White powder

Single Impurity(HPLC): 1.0%

Amino Acid Composition: 10% of theoretical

Peptide Content(N%): 80%(by %N)

Water Content(Karl Fischer): 6.0%

Acetate Content(HPIC): 15.0%

MS(ESI): N/A

Mass Balance: 95.0～105.0%

CJC-1295 DAC vs. CJC-1295 No DAC

CJC-1295 DAC and CJC-1295 (also known as Modified GRF 1-29) are both Growth Hormone Releasing Hormones (GHRH). Their action in the human body is identical but the difference between the two peptides are the span of the half-life. Modified GRF 1-29 and Sermorelin have a very short acting half-life of about 30 minutes, while CJC-1295 DAC has a half-life that can last up to approximately 8 days. Many a scientist have reported that the short half-life of Sermorelin and Modified GRF 1-29 is considered to be much more natural as they produce a short pulse of Human Growth Hormone.

Usage:An obstetric drug used to control postpartum hemorrhaging.